培土生金方预防脑卒中并发性肺炎疗效观察

Observation of the effect of peitushengjin prescription in the prevention of strokeassociated pneumonia

目的 :观察培土生金方预防脑卒中相关性肺炎的临床疗效。方法 :收集2012年5月—2014年5月收治的脑卒中患者80例,分为对照组40例和研究组40例,两组均接受常规治疗,研究组加服中药培土生金每天2次,每次400 ml,共7 d,用于预防脑卒中相关性肺炎的发生。比较两组治疗期间发生脑卒中相关性肺炎情况。结果 :对照组发生脑卒中相关性肺炎19例,占47.5%,研究组7例,占17.5%,研究组预防脑卒中相关性肺炎的效果优于对照,差异有统计学意义(P>0.05)。结论 :培土生金方预防脑卒中相关性肺炎发生有效,值得推广应用。

Objective： To observe the clinical effect of the peitushengjin prescription in the prevention of stroke-associated pneumonia. Methods： From May 2012 to May 2014, 80 cases of stroke were collected and divided into a control group and a research group with 40 cases each. The two groups were treated with the conventional therapy, and the research group was prescribed Chinese medicine peitushengjin （400 ml×2 daily） for 7 days in order to prevent stroke-associated pneumonia. The incidence of stroke-associated pneumonia was compared between the two groups. Results： Nineteen cases （47.5%） of the stroke-associated pneumonia were found in the control group and 7 cases （17.5%） in the research group. The preventive effect of stroke-associated pneumonia in the research group was better than that in the control group and the difference had the statistical significance（P〉0.05）. Conclusion： Peitushengjin prescription has the effect in the prevention of stroke-associated pneumonia and it is worthy of promotion.